| 1 |
34552337 | High Tumor Mutation Burden and DNA Repair Gene Mutations are Associated with Primary Resistance to Crizotinib in ALK-Rearranged Lung Cancer. | 2021 |
3 |
| 2 |
32871626 | Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing. | 2020 Nov |
2 |
| 3 |
32872120 | Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC. | 2020 Aug 28 |
1 |
| 4 |
30642546 | Concomitant resistance mechanisms to multiple tyrosine kinase inhibitors in ALK-positive non-small cell lung cancer. | 2019 Jan |
2 |
| 5 |
30843662 | Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer. | 2019 Apr |
3 |
| 6 |
29997966 | TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib. | 2018 May |
3 |